Figure Legends
int iCSC stably expressing dCas9-KRAB and sgRNA against CD44 (CD44-knockdown, CD44-kd) were transfected with blank expression vector (Ctrl) or CD44 3'UTR expression vector (CD44 3'UTR -overexpression, 3'UTR-oe). Nuclear run-on assay of ULBP2 promoter was performed; data were presented as means mean ± SD (n=3) (ns: no significance, *: p < 0.05).
(C) mRNA stability assay was performed in identical cells (Fig. S1B) .
(D) Half-life of ULBP2 mRNA was calculated based on mRNA stability assay.
(E) CD44 high iCSC and CD44 int iCSC were subjected to the NK cell cytotoxicity assay with NK-92 cells at different E:T ratios for 4 hours. Assays were performed either in the presence of anti-CD44 mAb or control IgG. Data were shown in means ± SD from three independent experiments which were performed in triplicate (ns: no significance).
(F) The IFN-γ release in the supernatants of cytotoxic assay (Fig. 2C , E:T ratio = 15:1) was determined by ELISA. Data were presented as mean ± SD (n=3) (ns: no significance).
